Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Verastem Inc., 3 years.
Verastem Inc.
Director
Puma Biotechnology Inc
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Puma Biotechnology Inc June 11, 202698.6%
-
Puma Biotechnology Inc June 11, 202599.1%
-
Puma Biotechnology Inc June 18, 202498.3%
-
Puma Biotechnology Inc June 13, 202388.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | Puma Biotechnology Inc | Open-market sale | −8,100 | $7.20 | $58,320 |
| Jun 11, 2026 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| May 21, 2026 | Verastem Inc. | Grant or award | +36,000 | — | — |
| Dec 16, 2025 | Verastem Inc. | Open-market sale | −592 | $9.14 | $5,411 |
| Sep 16, 2025 | Verastem Inc. | Open-market sale | −587 | $9.99 | $5,864 |
| Jun 16, 2025 | Verastem Inc. | Open-market sale | −594 | $5.65 | $3,356 |
| Jun 13, 2025 | Puma Biotechnology Inc | Open-market sale | −8,100 | $3.39 | $27,459 |
| Jun 11, 2025 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| May 22, 2025 | Verastem Inc. | Grant or award | +8,333 | — | — |
| Mar 17, 2025 | Verastem Inc. | Open-market sale | −593 | $6.95 | $4,121 |
| Dec 19, 2024 | Verastem Inc. | Open-market sale | −334 | $4.37 | $1,460 |
| Dec 16, 2024 | Verastem Inc. | Open-market sale | −595 | $4.54 | $2,701 |
| Sep 19, 2024 | Verastem Inc. | Open-market sale | −336 | $2.79 | $937 |
| Sep 16, 2024 | Verastem Inc. | Open-market sale | −600 | $2.80 | $1,680 |
| Jun 20, 2024 | Verastem Inc. | Open-market sale | −335 | $3.21 | $1,075 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.